Cargando…
Identification of patients with cancer with a high risk to develop delirium
Delirium deteriorates the quality of life in patients with cancer, but is frequently underdiagnosed and not adequately treated. In this study, we evaluated the occurrence of delirium and its risk factors in patients admitted to the hospital for treatment or palliative care in order to develop a pred...
Autores principales: | Neefjes, Elisabeth C. W., van der Vorst, Maurice J. D. L., Verdegaal, Bertha A. T. T., Beekman, Aartjan T. F., Berkhof, Johannes, Verheul, Henk M. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548884/ https://www.ncbi.nlm.nih.gov/pubmed/28688161 http://dx.doi.org/10.1002/cam4.1106 |
Ejemplares similares
-
Accuracy of the Delirium Observational Screening Scale (DOS) as a screening tool for delirium in patients with advanced cancer
por: Neefjes, Elisabeth C. W., et al.
Publicado: (2019) -
Olanzapine Versus Haloperidol for Treatment of Delirium in Patients with Advanced Cancer: A Phase III Randomized Clinical Trial
por: van der Vorst, Maurice J.D.L., et al.
Publicado: (2019) -
Prophylactic treatment for delayed chemotherapy-induced nausea and vomiting after non-AC based moderately emetogenic chemotherapy: a systematic review of randomized controlled trials
por: van der Vorst, Maurice J. D. L, et al.
Publicado: (2015) -
Optimal treatment of opioid induced constipation in daily clinical practice – an observational study
por: Neefjes, Elisabeth C. W., et al.
Publicado: (2019) -
Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin
por: van der Vorst, Maurice J. D. L., et al.
Publicado: (2019)